US · Healthcare

CEN Biotech Inc (CENBF)

Drug Manufacturers - Specialty & Generic

CEN Biotech Inc (CENBF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CENBF

P/E ratio

18.00

CEN Biotech Inc (CENBF) — FAQ

What is CENBF's P/E ratio?

The price-to-earnings (P/E) ratio for CEN Biotech Inc (CENBF) is 18.00 (data as of 2026-03-23).

Does CEN Biotech Inc pay a dividend?

Dividend yield is not available in the current snapshot for CEN Biotech Inc (CENBF). Check the MyAverix Finance app for the latest dividend data.

What sector is CEN Biotech Inc in?

CEN Biotech Inc (CENBF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CENBF listed on?

CENBF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)